Barely Significant
← all excerpts

Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin.

BMC Med · 2020 · PMC6966789 · PMID 31948461

Europe PMCDOI
1
hedged sentence
0.0890
closest p · 1.8× alpha
0.0890
boldest claim

The sentences

narrowly missed significancep = 0.089so close (0.05 < p ≤ 0.1)
Specifically, no significant between-group differences were found on the a priori primary outcome (MADRS score) at the primary endpoint (week 12), although the difference between rosuvastatin and placebo at week 12 narrowly missed significance ( p = 0.089).

also in 112 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.